These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37792003)

  • 1. Chimeric virus-like particles of human norovirus constructed by structure-guided epitope grafting elicit cross-reactive immunity against both GI.1 and GII.4 genotypes.
    Hou YN; Jin YQ; Zhang XF; Tang F; Hou JW; Liu ZM; Han ZB; Zhang H; Du LF; Shao S; Su JG; Liang Y; Zhang J; Li QM
    J Virol; 2023 Oct; 97(10):e0093823. PubMed ID: 37792003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype considerations for virus-like particle-based bivalent norovirus vaccine composition.
    Malm M; Tamminen K; Lappalainen S; Uusi-Kerttula H; Vesikari T; Blazevic V
    Clin Vaccine Immunol; 2015 Jun; 22(6):656-63. PubMed ID: 25903355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses.
    Debbink K; Lindesmith LC; Donaldson EF; Swanstrom J; Baric RS
    J Virol; 2014 Jul; 88(13):7256-66. PubMed ID: 24741081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norovirus GII.17 Virus-Like Particles Bind to Different Histo-Blood Group Antigens and Cross-React with Genogroup II-Specific Mouse Sera.
    Malm M; Tamminen K; Vesikari T; Blazevic V
    Viral Immunol; 2018 Dec; 31(10):649-657. PubMed ID: 30431404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous Immunization with Multivalent Norovirus VLPs Induces Better Protective Immune Responses to Norovirus Than Sequential Immunization.
    Malm M; Vesikari T; Blazevic V
    Viruses; 2019 Nov; 11(11):. PubMed ID: 31684058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs.
    Kocher J; Bui T; Giri-Rachman E; Wen K; Li G; Yang X; Liu F; Tan M; Xia M; Zhong W; Jiang X; Yuan L
    J Virol; 2014 Sep; 88(17):9728-43. PubMed ID: 24920797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypes.
    Malm M; Tamminen K; Heinimäki S; Vesikari T; Blazevic V
    Vaccine; 2018 Jan; 36(4):484-490. PubMed ID: 29246474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 protein.
    Malm M; Tamminen K; Vesikari T; Blazevic V
    Mol Immunol; 2016 Oct; 78():27-37. PubMed ID: 27573255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevailing Sydney like Norovirus GII.4 VLPs induce systemic and mucosal immune responses in mice.
    Huo Y; Wan X; Ling T; Wu J; Wang Z; Meng S; Shen S
    Mol Immunol; 2015 Dec; 68(2 Pt A):367-72. PubMed ID: 26375574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial.
    Lindesmith LC; Ferris MT; Mullan CW; Ferreira J; Debbink K; Swanstrom J; Richardson C; Goodwin RR; Baehner F; Mendelman PM; Bargatze RF; Baric RS
    PLoS Med; 2015 Mar; 12(3):e1001807. PubMed ID: 25803642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus.
    Heinimäki S; Hankaniemi MM; Sioofy-Khojine AB; Laitinen OH; Hyöty H; Hytönen VP; Vesikari T; Blazevic V
    Vaccine; 2019 Dec; 37(51):7509-7518. PubMed ID: 31585726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norovirus GII.4 strain antigenic variation.
    Lindesmith LC; Donaldson EF; Baric RS
    J Virol; 2011 Jan; 85(1):231-42. PubMed ID: 20980508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vesicular stomatitis virus as a vector to deliver virus-like particles of human norovirus: a new vaccine candidate against an important noncultivable virus.
    Ma Y; Li J
    J Virol; 2011 Mar; 85(6):2942-52. PubMed ID: 21228240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and antigenic diversity among noroviruses.
    Hansman GS; Natori K; Shirato-Horikoshi H; Ogawa S; Oka T; Katayama K; Tanaka T; Miyoshi T; Sakae K; Kobayashi S; Shinohara M; Uchida K; Sakurai N; Shinozaki K; Okada M; Seto Y; Kamata K; Nagata N; Tanaka K; Miyamura T; Takeda N
    J Gen Virol; 2006 Apr; 87(Pt 4):909-919. PubMed ID: 16528040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production, characterization and immunogenicity of P particles derived from norovirus GII.4 genotype 2004 variant.
    Su W; Gao J; Zang Y; Wu H; Wang L; Hu H; Yu X; Kong W; Jiang C
    Acta Virol; 2015 Mar; 59(1):33-9. PubMed ID: 25790049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Particle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope.
    Lindesmith LC; Donaldson EF; Beltramello M; Pintus S; Corti D; Swanstrom J; Debbink K; Jones TA; Lanzavecchia A; Baric RS
    J Virol; 2014 Aug; 88(16):8826-42. PubMed ID: 24872579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Luciferase Immunoprecipitation System (LIPS) assay for profiling human norovirus antibodies.
    Tin CM; Yuan L; Dexter RJ; Parra GI; Bui T; Green KY; Sosnovtsev SV
    J Virol Methods; 2017 Oct; 248():116-129. PubMed ID: 28673856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Antigenic Topology of Norovirus as Defined by B and T Cell Epitope Mapping: Implications for Universal Vaccines and Therapeutics.
    van Loben Sels JM; Green KY
    Viruses; 2019 May; 11(5):. PubMed ID: 31083353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of Novel Human Norovirus GII.17 Strains Correlates With Changes in Blockade Antibody Epitopes.
    Lindesmith LC; Kocher JF; Donaldson EF; Debbink K; Mallory ML; Swann EW; Brewer-Jensen PD; Baric RS
    J Infect Dis; 2017 Dec; 216(10):1227-1234. PubMed ID: 28973354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice.
    Tamminen K; Lappalainen S; Huhti L; Vesikari T; Blazevic V
    PLoS One; 2013; 8(7):e70409. PubMed ID: 23922988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.